In the August issue of Psychopharmacology, Johns Hopkins researchers published a study in which some subjects were given psilocybin and then asked to relate their experiences. Francisco Moreno of the University of Arizona published in the November issue of the Journal of Clinical Psychiatry his patients' reports that psilocybin helped them with migraine headaches. Harbor-UCLA Medical Center psychiatrist Charles Grob told the Chronicle of Higher Education that he is giving the compound to patients dying of cancer to see whether it eases pain by relieving anxiety.
Advertisement
Survey Series
For Advertisers
'Shroom Science: Safe and Effective?
Fifty years after its introduction to science, psilocybin returns to mainstream clinical research.
|
|||||||||
|
|||||||||
|
